Polpharma Group Announces Leadership Transition –Sebastian Szymanek appointed as its new President READ MORE October 27, 2025
Polpharma Group Supports Urgent EU Action to Safeguard Access to Medicines and Strengthen European Pharmaceutical Sovereignty READ MORE June 4, 2025
Polpharma Group Calls for Urgent Action to Protect early equitable access to medicines for European patients READ MORE May 15, 2025
Markus Sieger, CEO Polpharma Group, joins the Medicines for Europe as Vice President READ MORE March 11, 2022
Markus Sieger, CEO Polpharma Group, joins the CEO Advisory Committee established by IGBA READ MORE February 17, 2022
